Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron Patch for PONV Prevention in High-Risk Patients
NCT02457195Phase 2Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Feb 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Granisetron Hydrochloride Nasal Spray in postoperative nausea and vomiting (PONV), sponsored by Penn State Health Milton S. Hershey Medical Center. Started Feb 2016; status: completed.
02
Drugs
Granisetron Hydrochloride Nasal Spray
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02457195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457195.